Correlation Between SCI Pharmtech and Sinphar Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both SCI Pharmtech and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCI Pharmtech and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SCI Pharmtech and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on SCI Pharmtech and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCI Pharmtech with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCI Pharmtech and Sinphar Pharmaceutical.
Diversification Opportunities for SCI Pharmtech and Sinphar Pharmaceutical
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SCI and Sinphar is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding SCI Pharmtech and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and SCI Pharmtech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCI Pharmtech are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of SCI Pharmtech i.e., SCI Pharmtech and Sinphar Pharmaceutical go up and down completely randomly.
Pair Corralation between SCI Pharmtech and Sinphar Pharmaceutical
Assuming the 90 days trading horizon SCI Pharmtech is expected to generate 1.5 times more return on investment than Sinphar Pharmaceutical. However, SCI Pharmtech is 1.5 times more volatile than Sinphar Pharmaceutical Co. It trades about 0.13 of its potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about -0.13 per unit of risk. If you would invest 8,750 in SCI Pharmtech on September 12, 2024 and sell it today you would earn a total of 650.00 from holding SCI Pharmtech or generate 7.43% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
SCI Pharmtech vs. Sinphar Pharmaceutical Co
Performance |
Timeline |
SCI Pharmtech |
Sinphar Pharmaceutical |
SCI Pharmtech and Sinphar Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SCI Pharmtech and Sinphar Pharmaceutical
The main advantage of trading using opposite SCI Pharmtech and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCI Pharmtech position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.SCI Pharmtech vs. Apex Biotechnology Corp | SCI Pharmtech vs. Ruentex Development Co | SCI Pharmtech vs. WiseChip Semiconductor | SCI Pharmtech vs. Novatek Microelectronics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |